Author(s):
Deepak Prashar, Pooja Johri, Sanjay Kumar
Email(s):
prashardeepak99@yahoo.in
DOI:
10.52711/2231-5659.2021-11-2-10 
Address:
Dr. Deepak Prashar1*, Dr. Pooja Johri2, Dr. Sanjay Kumar3
1LR Institute of Pharmacy, Jablei-Kyar, Solan (H.P), India.
2MN DAV Dental College and Hospital, Tatul, Solan (H.P), India.
3Department of Economics, Government Degree College, Sarkaghat, (H.P.), India.
*Corresponding Author
Published In:
Volume - 11,
Issue - 2,
Year - 2021
ABSTRACT:
The Pharmaceutical aspects of the medications are very much essential for proper drug scheduling. But the economical prospect is also essential for the proper patient compliance. These two parameters act in symbiotic relationship. Therefore, there is always the prerequisite for combining these parameters as Pharmaco-economical. This present work tries to present the Pharmaceutical medications of HIV/AIDS from economical view point/scenario.
Cite this article:
Deepak Prashar, Pooja Johri, Sanjay Kumar. Pharmaco-Economical Projection of HIV/AIDS Therapy. Asian Journal of Research in Pharmaceutical Sciences. 2021; 11(2):151-4. doi: 10.52711/2231-5659.2021-11-2-10
Cite(Electronic):
Deepak Prashar, Pooja Johri, Sanjay Kumar. Pharmaco-Economical Projection of HIV/AIDS Therapy. Asian Journal of Research in Pharmaceutical Sciences. 2021; 11(2):151-4. doi: 10.52711/2231-5659.2021-11-2-10 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2021-11-2-10
REFERENCES:
1. https://aidsinfo.nih.gov/news/528/the-evidence-that-hiv-causes-aids
2. Groux H, O Garra A, Bigler M. et al. A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389: 737–742. https://doi.org/10.1038/39614
3. Douek D, Brenchley J, Betts M. et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature 2002; 417: 95–98. https://doi.org/10.1038/417095a
4. https://www.who.int/news-room/fact-sheets/detail/hiv-aids
5. Baghaei LA, Ghaffarzadegan N. Global Trends and Regional Variations in Studies of HIV/AIDS. Scientific Reports 2017; 7(1): 4170. doi:10.1038/s41598-017-04527-6
6. Sweileh WM. Global research output on HIV/AIDS–related medication adherence from 1980 to 2017. BMC Health Services Research. 2018; 18: 765. https://doi.org/10.1186/s12913-018-3568-x
7. Kaur KK, Kay T, Auwal SG. et al. A comparison of HIV/AIDS health policy in selected developed and developing countries. International Journal of Public Health and Clinical Sciences 2016; 3(3): 45-58.
9. Patel S, Patidar K. A Study to Assess the Effectiveness of Self Instructional Module on Knowledge Regarding HIV/AIDS among the Barbers in Mehsana City. Asian Journal of Nursing Education and Research 2017; 7(3): 281-283.
10. Mondal L. A co-relational study on job related stress, stress reaction and coping strategies adopted by nursing personnel providing care to PLHIVs at selected Medical College and Hospital, Kolkata. Asian J. Nursing Education and Research. 2020; 10(2):227-234. doi: 10.5958/2349-2996.2020.00049.X
11. Behera R. HIV/AIDS Among Displaced Women. Asian Journal of Management. 2018; 9(1):529-530.
12. Venkateshwarlu G, Ragyanaik E, Suma G, Santosh A, Sabat M. Recent Survey of IBS, HIV, TB, Uterus Cancer in Rural and Urban Development Areas. Asian Journal of Pharmaceutical Research 2014; 4(1): 36-38.
13. Kumar L, Prashar D. Recent Advancement of Indanol Derivatives and Their Biological Significance: A Review. Asian Journal of Research in Pharmaceutical Sciences 2012; 2(1): 9-11.
14. Spartalis MA. How HIV causes AIDS. Journal of the National Medical Association. 1995; 87(3):171‐173.
15. Simon V, Ho DD, Abdool Karim Q. HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet. 2006; 368(9534):489‐504. doi:10.1016/S0140-6736(06)69157-5
16. Barasa SS. True story about HIV: Theory of viral sequestration and reserve infection. HIV AIDS (Auckl). 2011; 3:125‐133. doi:10.2147/HIV.S26578
17. https://www.avert.org/hiv-transmission-prevention/myths
18. Swamy PGN, Varghese R, Patel PD. Effectiveness of STP on Knowledge and Attitude of Adolescent Students Regarding AIDS and its Prevention. International Journal of Advances in Nursing Management 2017; 5(4): 293-298.
19. Grigson S. A Study to assess the Effectiveness of Planned Teaching Program on Knowledge regarding HIV/AIDS among the students studying in selected school at Damoh. International Journal of Advances in Nursing Management 2019; 7(3):240-242.
20. Tufon EN, Bih AD, Alice M. Occurrence and Risk Factors for Opportunistic Infections in HIV Patients Attending the Bamenda Regional Hospital, Cameroon. International Journal of Nursing Education and Research 2014; 2(4): 381-384.
21. Patil SB, Moreshwar S. Effectiveness of Planned Teaching Program on Knowledge Regarding Antiretroviral Therapy (Art) and its Compliance Among People Living with HIV/Aids. International Journal of Nursing Education and Research 2015; 3(2): 172-182.
22. Beyrer C, Malinowska S, Kasia K. et al. 12 myths about HIV/AIDS and people who use drugs. Lancet. 2010; 376. 208-211. DOI: 10.1016/S0140-6736(10)61005-7.
23. https://www.mayoclinic.org/diseases-conditions/hiv-aids/symptoms-causes/syc-20373524
24. https://www.webmd.com/hiv-aids/guide/hiv-aids-complications
25. Sylvia J. A Care Map for a Youth Friendly Reproductive and Sexual Health Services (YFRSHS) For HIV/ Aids Prevention. International Journal of Advances in Nursing Management 2015; 3(3): 283-288.
26. Carolyn C, Selwyn PA. Complications of HIV Infection: A Systems-Based Approach. American Family Physician. 2011; 83(4): 395-406.
27. Arts EJ, Hazuda DJ. HIV-1 antiretroviral drug therapy. Cold Spring Harbor Perspectives in Medicine. 2012; 2(4):a007161. doi:10.1101/cshperspect.a007161
28. Atta MG, Seigneux SD, Lucas GM. Clinical Pharmacology in HIV Therapy. Clinical Journal of the American Society of Nephrology. 2019; 14 (3): 435-444. DOI: https://doi.org/10.2215/CJN.02240218
29. Bernardino JI, Arribas JR. 103 - Antiviral Therapy. Infectious Diseases (Fourth Edition). 2017; 2: 918-926. https://doi.org/10.1016/B978-0-7020-6285-8.00103-9
30. Allavena1 C, Trancart S, Cuzin L. Pharmacotherapy of HIV: A Focus on Atazanavir/Ritonavir a Potent and Convenient Once Daily Ritonavir Boosted Protease-Inhibitor for HIV-1 Infected Adults. Clinical Medicine: Therapeutics. 2009; 1:243–252.
31. Maenza J, Flexner C. Combination antiretroviral therapy for HIV infection. American Family Physician. 1998; 57(11): 2789-2798.
32. https://www.healthline.com/health/hiv-aids/understanding-the-aids-cocktail
33. Lansky A, Ward J. W, Jones J L. Combination antiretroviral therapy for HIV infection: policies and practices. AIDS. 1998; 12 (12):1552-1553.
34. https://www.goodrx.com/vemlidy
35. https://www.everydayhealth.com/hiv-aids/can-you-afford-hiv-treatment.aspx